ASP 아이소토프 (ASPI) 주가 전망: 목표주가, 배당, 최신 뉴스

ASP Isotopes Inc. , a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market.

Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs.

The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry.

In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

ASP Isotopes Inc.는 개발 단계의 첨단 소재 기업으로, 남아프리카공화국, 홍콩, 미국에서 동위원소의 생산·유통·마케팅·판매를 수행합니다. 회사는 2021년에 설립되어 본사는 Dallas, Texas에 있습니다. 사업은 두 개의 세그먼트인 Nuclear Fuels와 Specialist Isotopes and Related Services로 나뉩니다. Nuclear Fuels 세그먼트는 고농도 저농축 우라늄(HALEU)과 Lithium-6의 생산을 목표로 하는 첨단 원료용 연료 시장을 위한 기술 및 방법의 연구개발에 중점을 둡니다.

Specialist Isotopes and Related Services 세그먼트는 C-14, Mo-100, Si-28 등 고부가·저용량 동위원소를 분리하는 기술과 방법을 연구개발하고 관련 서비스를 제공하며 PET 실험실을 운영합니다. 회사는 Aerodynamic Separation Process (ASP) 기술(기체 종 및 동위원소 분리)과 Quantum Enrichment (QE) 기술(동위원소 분리)을 보유하고 있으며, 핵의료 산업용 Molybdenum-100, Molybdenum-98, Ytterbium-176을 생산·상품화하고 있습니다. 또한 Zinc-68, Nickel-64, Xenon-129/136(핵의료), Lithium-7, Uranium-235, Chlorine-37(에너지), Germanium-70/72/74(반도체) 등을 개발 중입니다.

• 주소: 2200 Ross Avenue, Suite 4575E, Dallas, TX 75201, United States

• 전화번호: 214 432 8219

• 웹사이트: https://aspisotopes.com

• 섹터: Basic Materials

• 산업: Chemicals

• 직원 수: 271